GNSS Nasdaq Household Audio & Video Equipment Financials FY2016βFY2025
Genasys Inc. had $40.8M of revenue in fiscal 2025, up 69.8% on the year before. Over five years, revenue changed β1.1% a year on average.
Last close Β· Oct 23, 2026
$1.48
1.7%Hi! I read Genasys Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+69.8%
Yes. Sales grew 69.8% last year.
Does it make a profit?
β44.4%
No. It lost money last year.
Does profit turn into cash?
β22.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Genasys Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
December 8, 2026
Tuesday Β· in 44 days
No past results dates on file yet.
KIRA Β· Genasys Inc. had $40.8M of revenue in fiscal 2025, up 69.8% on the year before. Over five years, revenue changed β1.1% a year on average. Its operating margin was β41.2%, up 70.0Β pts: of every 100 in sales, about β41 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· Genasys Inc. lost $18.1M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$9.0M in fiscal 2025, β22.1% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Genasys Inc. has $8.0M more cash than debt.
Cash, debt and the ratios that show how comfortably Genasys Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $18.9M | $19.1M | $10.1M | $12.9M | $8.0M |
| Debt incl. finance leases | $0.3M | $0.0M | β | β | $0.0M |
| Net debt / EBITDA | β6.9x | β | β | β | β |
| Debt / equity | 0.0x | 0.0x | β | β | 0.0x |
| Interest coverage | β | β | β | β44.3x | β10.7x |
| Current ratio | 2.0x | 2.3x | 2.2x | 1.9x | 0.7x |
| Quick ratio | 1.7x | 1.9x | 1.7x | 1.3x | 0.6x |
| Total assets | $90.1M | $71.9M | $49.9M | $53.9M | $63.9M |
| Total liabilities | $24.2M | $21.5M | $16.1M | $36.4M | $61.7M |
| Shareholders' equity | $50.4M | $50.4M | $33.8M | $17.6M | $2.2M |
| Net debt (β = net cash) | β$18.6M | β$19.1M | β | β | β$8.0M |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· Genasys Inc. passes 3 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 8 | 3 / 8 | 7 / 9 | 6 / 9 | 4 / 9 | 6 / 9 | 2 / 8 | 1 / 8 | 3 / 8 |
| Accruals ratio | β0.4% | β0.6% | β12.4% | β15.9% | 8.7% | β7.0% | β20.6% | β14.5% | β23.6% | β15.9% |
| Altman Z'' | 15.42 | 9.77 | 2.87 | 3.34 | 4.54 | 2.09 | 0.25 | β2.41 | β7.87 | β9.71 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $16.4M | $20.3M | $26.3M | $37.0M | $43.0M | $47.0M | $54.0M | $46.7M | $24.0M | $40.8M |
| Gross profit | $7.7M | $10.3M | $12.7M | $18.5M | $22.6M | $23.4M | $27.3M | $21.8M | $10.2M | $17.0M |
| Research and development | $2.4M | $2.5M | $3.5M | $4.5M | $4.6M | $4.9M | $7.0M | $8.1M | $9.6M | $8.1M |
| Operating income | β$1.6M | β$0.8M | β$1.5M | $3.1M | $6.0M | $1.1M | β$15.5M | β$11.0M | β$26.7M | β$16.8M |
| Interest expense | β | β | $0.0M | β | β | β | β | β | $0.6M | $1.6M |
| Pretax income | β$1.5M | β$0.7M | β$1.4M | $3.4M | $6.2M | $1.1M | β$15.5M | β$11.0M | β$32.1M | β$18.0M |
| Income tax | β$0.2M | $0.2M | $2.4M | $0.6M | β$5.7M | $0.4M | $0.7M | $7.4M | β$0.4M | $0.1M |
| Net income | β$1.3M | β$0.9M | β$3.7M | $2.8M | $11.9M | $0.7M | β$16.2M | β$18.4M | β$31.7M | β$18.1M |
| Net income to common | β$1.3M | β$0.9M | β$3.7M | β | β | β | β | β | β | β |
| Diluted EPS | β$0.04 | β$0.03 | β$0.12 | $0.08 | $0.35 | $0.02 | β$0.44 | β$0.50 | β$0.72 | β$0.40 |
| Diluted shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B | 0.04B | 0.04B | 0.04B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | β$1.1M | β$0.7M | $1.3M | $9.9M | $6.9M | $6.2M | $0.5M | β$9.6M | β$19.5M | β$8.8M |
| Capital expenditure | $0.2M | $0.2M | $0.6M | $0.3M | $0.1M | $0.2M | $0.4M | $0.2M | $0.2M | $0.3M |
| Free cash flow | β$1.3M | β$0.8M | $0.6M | $9.5M | $6.8M | $5.9M | $0.1M | β$9.8M | β$19.6M | β$9.0M |
| Depreciation and amortization | $0.2M | $0.2M | $0.5M | $0.8M | $0.8M | $1.6M | $2.6M | $2.6M | $2.9M | $2.8M |
| Stock-based compensation | $0.6M | $1.1M | $0.6M | $0.7M | $1.0M | $1.4M | $2.2M | $1.6M | $1.7M | $1.7M |
| Acquisitions | β | β | $2.4M | β | $0.0M | $15.8M | $0.0M | $0.0M | $0.9M | $0.0M |
| Share buybacks | $1.7M | β | $0.7M | $2.2M | $0.4M | $0.0M | $1.0M | $0.0M | β | β |
| Dividends paid | $1.0M | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β |
| Dividends and buybacks | $2.7M | $0.0M | $0.7M | $2.2M | $0.4M | $0.0M | $1.0M | $0.0M | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $16.4M | $17.1M | $14.7M | $22.5M | $27.6M | $18.9M | $19.1M | $10.1M | $12.9M | $8.0M |
| Total debt | β | β | $0.3M | $0.3M | $0.3M | $0.3M | $0.0M | β | β | $0.0M |
| Current assets | $25.2M | $29.0M | $27.7M | $34.0M | $40.1M | $35.5M | $35.6M | $25.2M | $26.1M | $39.3M |
| Current liabilities | $2.1M | $3.7M | $6.6M | $9.3M | $10.3M | $17.5M | $15.4M | $11.3M | $14.1M | $54.4M |
| Inventory | $4.8M | $5.3M | $6.7M | $5.8M | $5.9M | $6.4M | $6.0M | $6.5M | $7.3M | $8.8M |
| Property and equipment, net | $0.5M | $0.5M | $2.4M | $2.3M | $1.9M | $1.8M | $1.8M | $1.6M | $1.3M | $1.1M |
| Goodwill | β | β | $2.4M | $2.3M | $2.5M | $23.8M | $10.1M | $10.3M | $13.3M | $13.5M |
| Intangible assets | $0.1M | $0.1M | $1.6M | $1.2M | $0.9M | $12.8M | $10.5M | $8.4M | $8.5M | $6.1M |
| Total assets | $36.8M | $38.9M | $41.9M | $47.1M | $66.2M | $90.1M | $71.9M | $49.9M | $53.9M | $63.9M |
| Total liabilities | $2.2M | $3.7M | $8.4M | $11.7M | $17.0M | $24.2M | $21.5M | $16.1M | $36.4M | $61.7M |
| Preferred stock | $0.0M | $0.0M | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $34.6M | $35.2M | $33.5M | $35.4M | $49.1M | $50.4M | $50.4M | $33.8M | $17.6M | $2.2M |
| Margins | ||||||||||
| Gross margin | 46.9% | 50.6% | 48.4% | 49.9% | 52.6% | 49.8% | 50.5% | 46.6% | 42.4% | 41.6% |
| Operating margin | β9.7% | β4.0% | β5.6% | 8.5% | 14.0% | 2.3% | β28.7% | β23.5% | β111.3% | β41.2% |
| EBITDA margin | β8.7% | β3.2% | β3.8% | 10.7% | 15.9% | 5.7% | β24.0% | β18.1% | β99.1% | β34.4% |
| Net margin | β7.8% | β4.3% | β14.2% | 7.5% | 27.6% | 1.5% | β30.0% | β39.4% | β132.2% | β44.4% |
| FCF margin | β8.0% | β4.2% | 2.4% | 25.7% | 15.8% | 12.6% | 0.2% | β21.1% | β81.8% | β22.1% |
| Returns | ||||||||||
| Return on capital | β | β | β6.1% | 19.7% | 27.6% | 2.2% | β39.2% | β | β | β |
| Return on capital employed | β4.6% | β2.3% | β4.2% | 8.3% | 10.8% | 1.5% | β27.5% | β28.4% | β67.0% | β178.2% |
| Return on equity | β3.7% | β2.5% | β10.9% | 8.1% | 28.1% | 1.4% | β32.2% | β43.7% | β123.5% | β183.6% |
| Return on assets | β3.5% | β2.3% | β9.3% | 6.3% | 21.0% | 0.9% | β20.0% | β30.2% | β61.1% | β30.7% |
| Return on tangible equity | β3.7% | β2.5% | β12.7% | 8.7% | 26.0% | 5.1% | β54.5% | β121.8% | β | β |
| Growth | ||||||||||
| Revenue growth | β | 24.2% | 29.5% | 40.6% | 16.3% | 9.3% | 15.0% | β13.6% | β48.6% | 69.8% |
| Net income growth | β | β | β | β | 326.4% | β94.1% | β2,402.8% | β | β | β |
| EPS growth | β | β | β | β | 337.5% | β94.3% | β2,300.0% | β | β | β |
| FCF growth | β | β | β | 1,419.5% | β28.7% | β12.3% | β98.5% | β11,401.1% | β | β |
| Share count change | β | β0.4% | 2.0% | 2.8% | 2.1% | 4.4% | 2.5% | 1.2% | 20.0% | 1.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β5.6x | β4.0x | β6.9x | β | β | β | β |
| Debt / equity | β | β | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | β | β | 0.0x |
| Interest coverage | β | β | β70.6x | β | β | β | β | β | β44.3x | β10.7x |
| Current ratio | 12.1x | 7.9x | 4.2x | 3.7x | 3.9x | 2.0x | 2.3x | 2.2x | 1.9x | 0.7x |
| Quick ratio | 9.8x | 6.5x | 3.2x | 3.0x | 3.3x | 1.7x | 1.9x | 1.7x | 1.3x | 0.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 0.9% | 2.4% | 0.9% | 0.3% | 0.4% | 0.7% | 0.5% | 0.8% | 0.6% |
| Stock comp / revenue | 3.7% | 5.5% | 2.2% | 2.0% | 2.3% | 3.0% | 4.1% | 3.5% | 6.9% | 4.1% |
| Payouts / FCF | β | β | 115.9% | 22.8% | 5.9% | 0.0% | 1,147.1% | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 3.0 | 7.0 | 6.0 | 4.0 | 6.0 | 2.0 | 1.0 | 3.0 |
| Altman Z'' | 15.4 | 9.8 | 2.9 | 3.3 | 4.5 | 2.1 | 0.3 | β2.4 | β7.9 | β9.7 |
| Accruals ratio | β0.4% | β0.6% | β12.4% | β15.9% | 8.7% | β7.0% | β20.6% | β14.5% | β23.6% | β15.9% |
Source: SEC EDGAR XBRL filings (CIK 0000924383). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
